Clinical trialNCT00766597CompletedPhase 1/PHASE2Interventional

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment9HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Complications with current HIV antiretroviral therapy have left many children and adolescents with limited therapeutic options due to drug resistance. The purpose of this study is to test the effectiveness and safety of Vicriviroc (VCV), an HIV entry inhibitor and CCR5 co-receptor antagonist.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Rolando M Viani, M.D., M.T.P.
University of California
Study Chair
clinicaltrials.gov ↗
Stephen A Spector, M.D.
University of California, San Diego
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

Univ. of Puerto Rico Ped. Hiv/aids Research Program Crs
San Juan, Puerto Rico

United States

Ucsd Mother-Child-Adolescent Program Crs
San Diego, California, United States
Children'S National Med. Ctr. Washington Dc Nichd Crs
Washington D.C., District of Columbia, United States
Howard Univ. Washington Dc Nichd Crs
Washington D.C., District of Columbia, United States
Chicago Children'S Crs
Chicago, Illinois, United States
Metropolitan Hosp. Nichd Crs
New York, New York, United States
Bronx-Lebanon Hosp. Impaact Crs
The Bronx, New York, United States
Jacobi Med. Ctr. Bronx Nichd Crs
The Bronx, New York, United States
St. Jude/uthsc Crs
Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Vicriviroc

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2009
Primary completion: 31 Jul 2010
Completion: 31 Aug 2010
Last update posted: 5 Nov 2021
Registered enrollment: 9
Registry id: NCT00766597

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.